Showing results (191-200 of 235) with videos related to
Sort By:
Pageof 24
Cancer Immunology Research|January 17, 2014
Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-IAude G Chapuis, Olga K Afanasiev, Jayasri G Iyer, et al.Plos Computational Biology|January 16, 2026
TCR2HLA: Calibrated inference of HLA genotypes from TCR repertoires enables identification of immunologically relevant metaclonotypesKoshlan Mayer-Blackwell, Anastasia Minervina, Mikhail Pogorelyy, et al.Open Forum Infectious Diseases|February 21, 2024
Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster VaccineTara M Babu, Xiaoying Shen, R Scott McClelland, et al.Cell Reports|April 23, 2024
HSV-1 employs UL56 to antagonize expression and function of cGAMP channelsHenry T W Blest, Alexander Redmond, Jed Avissar, et al.Nature Biotechnology|November 20, 2018
T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide-MHC complexesAmalie K Bentzen, Lina Such, Kamilla K Jensen, et al.Nature Communications|November 14, 2022
Selective retention of virus-specific tissue-resident T cells in healed skin after recovery from herpes zosterKerry J Laing, Werner J D Ouwendijk, Victoria L Campbell, et al.Immunohorizons|August 6, 2020
Proteome-Wide Zika Virus CD4 T Cell Epitope and HLA Restriction DeterminationVictoria L Campbell, LeAnn Nguyen, Elise Snoey, et al.Scientific Reports|March 14, 2017
Worldwide circulation of HSV-2 × HSV-1 recombinant strainsDavid M Koelle, Peter Norberg, Matthew P Fitzgibbon, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 27, 2016
Extensive CD4 and CD8 T Cell Cross-Reactivity between AlphaherpesvirusesLichen Jing, Kerry J Laing, Lichun Dong, et al.Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccineEmily S Ford, Alvason Li, Kerry J Laing, et al.Pageof 24